Although receipt of at least 1 dose of COVID-19 vaccine among adults is high, only about one in six U.S. adults have received the updated (bivalent) booster vaccine (17.3% in January 2023) despite the CDC recommendation in November 2021 for all
On December 10, 2020, Pfizer presented results from a 36,000-person, two-dose, prospective, placebo-controlled trial of its Covid-19 messenger RNA (mRNA) vaccine, BNT162b2, to the Food and Drug Administration (FDA).1 The vaccine was 95% effective at
The number of COVID-19 cases and deaths has continued to decline globally, with 3.1 million new cases and just over 54,000 new deaths, reported over the last week, according to the World Health Organization (WHO).
Compared to the first year of the COVID-19 pandemic, 2021 was “undoubtedly worse” for the Americas, where infections and deaths tripled, the top UN health official there reported on Wednesday.
The number of new COVID-19 cases reported to the UN health agency has declined for seven weeks in a row, in what the top official there called on Monday “the longest sequence of weekly declines during the pandemic so far”.
More than eight million new COVID-19 cases were reported in the Americas last week, the highest weekly caseload since the start of the pandemic, the head of the regional office of the World Health Organization (WHO) told journalists on Wednesday.
Deaths from tuberculosis – one of the top infectious killers in the world - have increased for the first time in a decade, as a direct result of the COVID-19 pandemic, the World Health Organization (WHO) said on Thursday.